SAGE and the American College of Clinical Pharmacology (ACCP) announce the launch of Clinical Pharmacology in Drug Development (CPDD), a new peer-reviewed journal focused on publishing research findings from drug development studies. This is the ACCP’s second scholarly journal having published The Journal of Clinical Pharmacology, a world renowned title that has been published for more than 50 years.
“We are very excited about the launch of CPDD, which should provide a source to publish results from late preclinical and early clinical drug development studies,” said Michael J. Fossler, Jr., Pharm.D., Ph.D., ACCP President. “ACCP is happy to continue its relationship with SAGE on this new journal, and we are confident that CPDD will quickly become the primary source for publication of articles in this important area within clinical pharmacology”.
As required by law, the U.S. Food and Drug Administration has recently begun to require the entry of clinical trials in a public registry prior to subject enrollment as a condition of consideration for publication of the trial results. In addition, pharmaceutical and biotechnology companies are being encouraged to publish all clinical trial results. CPDD should facilitate compliance with these requirements, and expand the availability of vitally important information on new drugs and biologics in development. With the information available, centers like the Pennsylvania IOP rehabs can research changes in treatments for patients facing addiction issues to check whether the new drug helps to speed up the recovery process or not.
Clinical Pharmacology in Drug Development encourages the submission of original research papers. Acceptance is determined by scientific rigor and technical soundness rather than perceived importance of the presented results; negative study results are explicitly not summarily rejected.
Clinical Pharmacology in Drug Development is an online-only journal that will only be available in print form for purchase by request. The new journal will be available free of charge to ACCP members.
“Clinical Pharmacology in Drug Development is a great new venture for the ACCP and we’re excited to be a part of it,” said Bob Howard, Executive Director, US Journals. “Having been the ACCP’s publishing partner for its flagship title since 1999, The Journal of Clinical Pharmacology, we are confident it will be as successful and a benefit to ACCP members, the pharmacology community, and all who have an interest in drug development.”